✦ LIBER ✦

Multicentre phase I–II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study

✍ Scribed by Adalsteinn Gunnlaugsson; Harald Anderson; Pehr Lind; Bengt Glimelius; Anders Johnsson

Book ID: 118497689
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 221 KB
Volume: 95
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2010.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicentre phase II trial of capecitabi

Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study

✍ Adalsteinn Gunnlaugsson; Harald Anderson; Eva Fernebro; Elisabeth Kjellén; Per B 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Phase II study of gemcitabine, oxaliplat

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

✍ Hezel, A F; Noel, M S; Allen, J N; Abrams, T A; Yurgelun, M; Faris, J E; Goyal, 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 277 KB

Phase I/II trial of capecitabine and oxa

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

✍ Hoehler, T; von Wichert, G; Schimanski, C; Kanzler, S; Moehler, M H; Hinke, A; S 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

A phase I/II, non-randomized, feasibilit

A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer

✍ Sil Kordes, Dick J. Richel, Heinz-Josef Klümpen, Mariëtte J. Weterman, Arnoldus 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 181 KB

Epirubicin, Oxaliplatin, and Capecitabin

Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial

✍ Okines, A. F. C.; Ashley, S. E.; Cunningham, D.; Oates, J.; Turner, A.; Webb, J. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 122 KB

Phase II study of S-1 combined with oxal

Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity

✍ Kim, K-p; Jang, G; Hong, Y S; Lim, H-S; Bae, K-s; Kim, H-S; Lee, S S; Shin, J-G; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 414 KB